Gallic acid as a Sestrin (SESN2) activator and potential obesity therapeutic agent: A molecular docking study-Reference-Cited by-同舟云学术

Gallic acid as a Sestrin (SESN2) activator and potential obesity therapeutic agent: A molecular docking study

Published:2023-10 Issue: Volume:883 Page:147683
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Sousa Jaciara Neves,Queiroz Lorena dos Reis Pereira,de Paula Alfredo Maurício Batista,Guimarães André Luiz Sena,Lescano Caroline Honaiser,Aguilar Charles Martins,Pires de Oliveira Ivan,Santos Sérgio Henrique Sousa

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference49 articles.

1. Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review;AL Zahrani;Eur. J. Med. Chem.,2020

2. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation;Bray;Obes. Rev.,2017

3. Stressin' Sestrins take an aging fight;Budanov;EMBO Mol. Med.,2010

4. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1;Chantranupong;Cell Rep.,2014

5. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice;Chao;PLoS One,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of gallic acid and physical training on liver damage, force, and anxiety in obese mice: Hepatic modulation of Sestrin 2 (SESN2) and PGC-α expression;Gene;2024-10

2. Guava leaf extract attenuated muscle proteolysis in dexamethasone induced muscle atrophic mice via ubiquitin proteasome system, mTOR-autophagy, and apoptosis pathway;Nutrition Research;2024-07

3. Sestrin2 in diabetes and diabetic complications;Frontiers in Endocrinology;2023-10-18